Es gab 50 kürzliche Insider-Transaktionen für iTeos Therapeutics, Inc. (ITOS), darunter 31 Käufe und 14 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $83.46M und die gesamten Insider-Verkäufe auf $25.43M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Detheux Michel, Hallal David, Ecor1 Capital, Llc. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ITOS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-10 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,883 |
$10.02 |
$439.71K |
- |
| 2025-06-09 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.03 |
$440.14K |
- |
| 2025-06-06 |
Hallal David |
Director |
Optionsausübung (Verkauf) |
38,228 |
$4.30 |
$164.38K |
- |
| 2025-06-06 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.21 |
$448.04K |
- |
| 2025-06-05 |
Hallal David |
Director |
Informierter Verkauf |
38,227 |
$10.15 |
$388K |
- |
| 2025-06-05 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.15 |
$445.4K |
- |
| 2025-06-04 |
Hallal David |
Director |
Informierter Verkauf |
38,227 |
$10.07 |
$384.95K |
- |
| 2025-06-04 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,883 |
$10.10 |
$443.22K |
- |
| 2025-05-15 |
Ecor1 Capital, Llc |
10 Percent Owner |
Informierter Kauf |
3,300,000 |
$8.00 |
$26.4M |
10,688,978 |
| 2025-05-14 |
Ecor1 Capital, Llc |
10 Percent Owner |
Informierter Kauf |
1,658,978 |
$7.41 |
$12.29M |
7,388,978 |
| 2025-05-13 |
Ecor1 Capital, Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
5,730,000 |
| 2025-05-13 |
Van Hauwermeiren Timothy |
Director |
Optionsausübung (Verkauf) |
22,346 |
$4.30 |
$96.09K |
- |
| 2025-05-13 |
Gadicke Ansbert |
Other: Former 10% Owner |
Informierter Verkauf |
1,031,931 |
$8.06 |
$8.32M |
3,452,797 |
| 2025-05-13 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
Informierter Verkauf |
630,191 |
$8.06 |
$5.08M |
2,108,594 |
| 2025-05-13 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
Informierter Verkauf |
630,191 |
$8.06 |
$5.08M |
2,108,594 |
| 2025-03-07 |
Gall Matthew |
Chief Financial Officer |
RSU-Zuteilung |
24,000 |
- |
- |
89,429 |
| 2025-03-07 |
Detheux Michel |
Chief Executive Officer |
RSU-Zuteilung |
77,000 |
- |
- |
135,903 |
| 2025-03-07 |
Call Matthew |
Chief Operating Officer |
RSU-Zuteilung |
145,000 |
$7.05 |
$1.02M |
145,000 |
| 2025-03-07 |
Mcgrath Yvonne |
Chief Scientific Officer |
RSU-Zuteilung |
15,300 |
- |
- |
46,300 |
| 2024-12-06 |
Feltquate David |
Chief Medical Officer |
RSU-Zuteilung |
47,000 |
- |
- |
47,000 |
| 2024-11-19 |
Gall Matthew |
Chief Financial Officer |
Informierter Kauf |
5,000 |
$7.73 |
$38.64K |
65,429 |
| 2024-08-08 |
Detheux Michel |
Chief Executive Officer |
Schenkung (gegeben) |
442,800 |
$11.58 |
$5.13M |
147,600 |
| 2024-08-01 |
Feltquate David |
Chief Medical Officer |
RSU-Zuteilung |
350,000 |
$17.46 |
$6.11M |
350,000 |
| 2024-07-31 |
Feltquate David |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-06-11 |
Rhoads Ann D |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Hallal David |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Davis Aaron I. |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Ho Tony W |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Iannone Robert |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Van Hauwermeiren Timothy |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Desimone Jill |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Lee David K |
Director |
RSU-Zuteilung |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-05-12 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
Sonstige (Verkauf) |
900,000 |
- |
- |
2,545,510 |
| 2024-05-10 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
Informierter Kauf |
5,714,285 |
$0.00 |
$5.71K |
5,714,285 |
| 2024-05-10 |
Boxer Capital, Llc |
Other: See Remarks |
RSU-Zuteilung |
1,142,857 |
$17.50 |
$20M |
2,946,915 |
| 2024-03-07 |
Desimone Jill |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-03-07 |
Desimone Jill |
Director |
RSU-Zuteilung |
44,766 |
$11.58 |
$518.39K |
44,766 |
| 2024-03-07 |
Gall Matthew |
Chief Financial Officer |
RSU-Zuteilung |
163,200 |
$11.58 |
$1.89M |
163,200 |
| 2024-03-07 |
Detheux Michel |
Chief Executive Officer |
RSU-Zuteilung |
590,400 |
$11.58 |
$6.84M |
590,400 |
| 2024-03-07 |
Call Matthew |
Chief Operating Officer |
RSU-Zuteilung |
225,000 |
$11.58 |
$2.61M |
225,000 |
| 2024-03-07 |
Mcgrath Yvonne |
Chief Scientific Officer |
RSU-Zuteilung |
153,600 |
$11.58 |
$1.78M |
153,600 |
| 2023-12-05 |
Gall Matthew |
Chief Financial Officer |
RSU-Zuteilung |
41,000 |
- |
- |
60,429 |
| 2023-12-05 |
Detheux Michel |
Chief Executive Officer |
RSU-Zuteilung |
30,000 |
- |
- |
58,903 |
| 2023-12-05 |
Call Matthew |
Chief Operating Officer |
RSU-Zuteilung |
44,000 |
- |
- |
137,898 |
| 2023-12-05 |
Mcgrath Yvonne |
Chief Scientific Officer |
RSU-Zuteilung |
31,000 |
- |
- |
31,000 |
| 2023-12-05 |
Lee David K |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-05 |
Lee David K |
Director |
RSU-Zuteilung |
44,766 |
$9.84 |
$440.5K |
44,766 |
| 2023-10-12 |
Gall Matthew |
Chief Financial Officer |
Informierter Kauf |
5,000 |
$8.37 |
$41.85K |
19,429 |
| 2023-08-23 |
Boxer Capital, Llc |
Officer |
Informierter Verkauf |
219,638 |
$16.87 |
$3.71M |
1,804,058 |
| 2023-06-13 |
Rhoads Ann D |
Director |
RSU-Zuteilung |
22,383 |
$14.77 |
$330.6K |
22,383 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
